Transparency,
Competition Key to Lower Drug Prices
By Mark Hahn
March 12, 2019
Since
announcing his decision to return to the helm of the Senate Finance Committee,
Senator Chuck Grassley has been working tirelessly to fulfill a policy priority
to improve “the affordability, quality and accessibility of health care.”
announcing his decision to return to the helm of the Senate Finance Committee,
Senator Chuck Grassley has been working tirelessly to fulfill a policy priority
to improve “the affordability, quality and accessibility of health care.”
Nowhere
has this been more pronounced than his efforts to rein in out of control drug
prices and increase transparency and competition in an otherwise murky
marketplace. As Chairman, he has already organized a series of hearings on
“Drug Pricing in America” bringing forward patients, policy experts, and
industry executives to examine ways to increase affordability of and patient
access to life-saving prescription drugs.
has this been more pronounced than his efforts to rein in out of control drug
prices and increase transparency and competition in an otherwise murky
marketplace. As Chairman, he has already organized a series of hearings on
“Drug Pricing in America” bringing forward patients, policy experts, and
industry executives to examine ways to increase affordability of and patient
access to life-saving prescription drugs.
These
hearings have demonstrated the commitment the Republican Senate majority has to
make healthcare more affordable for the American public and are a strong
complement to the efforts that the Trump administration has been undertaking to
bring reform to America’s broken drug pricing system.
hearings have demonstrated the commitment the Republican Senate majority has to
make healthcare more affordable for the American public and are a strong
complement to the efforts that the Trump administration has been undertaking to
bring reform to America’s broken drug pricing system.
…
The
Administration should follow Senator Grassley’s lead in holding drug companies
accountable for high prices.
Administration should follow Senator Grassley’s lead in holding drug companies
accountable for high prices.
Lowering
the cost of healthcare won’t be easy, but it is possible. As Congress and the
Administration work through drug pricing reform, it is important that they keep
a focus on these true drivers of cost while working to make healthcare more
affordable for all Americans.
the cost of healthcare won’t be easy, but it is possible. As Congress and the
Administration work through drug pricing reform, it is important that they keep
a focus on these true drivers of cost while working to make healthcare more
affordable for all Americans.
Mark
Hahn is a Sioux City, Iowa-based radio host.
Hahn is a Sioux City, Iowa-based radio host.